Jafron Presented at the 41st Vicenza Course and 60th ERA Congress
Two successful events, the 41st Vicenza Course on AKI&CRRT held from June 12th to 14th in Vicenza, Italy and the 60th Congress of the European Renal Association (ERA) held from June 15th to 18th in Milan, Italy, had concluded one after another. Both had been extremely good occasions to present Jafron’s HA series hemoadsorption cartridges and adsorption device Future F20 which attracted lots of people to stop by at our booth to know more.
It was an incredible chance for us to be a part of these two extraordinary gatherings of industry leaders, especially to see a lot of friends and share our updates with many medical professionals. We were grateful to have had the opportunity to exchange valuable insights with clinicians and medical professors at our booth and in the academic activities.
There were new and exciting topical subjects in our program, for instance the Meet the Expert on “Hemoadsorption Therapy” and two symposiums on “The new frontier in blood purification” (June 12th) and “Hemoadsorption in Chronic and Acute Clinical Settings” (June 16th) which were held respectively in Vicenza and Milan. During the symposium in Vicenza on June 12th, the renowned experts Prof. Rinaldo Bellomo from Australia, Prof. Claudio Ronco from Italy, Prof. Igor Milet from Portugal, Prof. Fethi Gul from Turkey presented Jafron hemoadsorption technology and its clinical application in CKD, intensive care as well as crush syndrome which got surprisingly positive feedback. In the symposium in Milan on June 16th, well-known professors such as Prof. Thomas Rimmelé from France, Prof. Vincenzo Cantaluppi from Italy, and Prof. Jinjun Chen from China, delivered excellent presentations which lead the audience to explore together how blood purification in hyperinflammatory critical ill patients works, how can hemoadsorption help to improve uremic complications, and how to apply hemoadsorption in septic and severe burn patients. They shared their experiences with the treatment of DPMAS, the results of the PADSTONE study on 1300 patients, as well as new scientific evidence and progress in Hemoadsorption which inspired many among the audience. Hundreds of experts and doctors from Europe, Latam, and Asia involved in our symposium sessions showed interest, and communicated with our chairman and speakers face to face.
The curiosity for hemoadsorption doesn't have to end! Join us in the exploration of our cutting-edge hemoadsorption technologies and their clinical application and potential use. Stay connected for the upcoming events in Milan and Vienna in October!